Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5427]
News [12613]
Articles [172]
Editorials [5]
Conferences [246]
elearning [17]
Current indications for CDK 4/6 inhibitors (plus antiestrogen), biomarkers
Dr Sibylle Loibl - German Breast Cancer Group
Current indications for CDK 4/6 inhibitors (plus antiestrogen), biomarkers ( Dr Sibylle Loibl - German Breast Cancer Group )
26 Oct 2016
Coming of age for CDK 4/6 inhibitors: Interactive session and close
Dr Giuesppe Curigliano - European Institute of Oncology, Milan, Italy
Coming of age for CDK 4/6 inhibitors: Interactive session and close ( Dr Giuesppe Curigliano - European Institute of Oncology, Milan, Italy )
26 Oct 2016
Biomarkers of sensitivity and resistance
Dr Joan Seoane - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Biomarkers of sensitivity and resistance ( Dr Joan Seoane - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
26 Oct 2016
Editor's ESMO 2016 roundup
Prof Gordon McVie - Editor in Chief, ecancer
Editor's ESMO 2016 roundup ( Prof Gordon McVie - Editor in Chief, ecancer )
24 Oct 2016
Abiraterone in patients with recurrent epithelial ovarian cancer
Dr Susanna Banerjee - The Royal Marsden, London, UK
Abiraterone in patients with recurrent epithelial ovarian cancer ( Dr Susanna Banerjee - The Royal Marsden, London, UK )
24 Oct 2016
Fatigue in men with castration resistant prostate cancer treated with...
Dr Simon Chowdhury - Guy's Hospital, London, UK
Fatigue in men with castration resistant prostate cancer treated with enzalutamide ( Dr Simon Chowdhury - Guy's Hospital, London, UK )
21 Oct 2016
CDK4/6 inhibition: PALOMA2 versus MONALEESA2
Dr Michael Gnant - Medizinischen Universität Wien, Vienna, Austria
CDK4/6 inhibition: PALOMA2 versus MONALEESA2 ( Dr Michael Gnant - Medizinischen Universität Wien, Vienna, Austria )
17 Oct 2016
First evidence of significant clinical activity of PD1 inhibition in metastatic...
Dr Julie Graff - Knight Cancer Institute, Oregon Health & Science University...
First evidence of significant clinical activity of PD1 inhibition in metastatic prostate cancer ( Dr Julie Graff - Knight Cancer Institute, Oregon Health & Science University, Portland, USA )
17 Oct 2016
TRAIL induced apoptosis for cancer stem cells
Prof Waleed Arafat - Alexandria Faculty of Medicine, Alexandria, Egypt
TRAIL induced apoptosis for cancer stem cells ( Prof Waleed Arafat - Alexandria Faculty of Medicine, Alexandria, Egypt )
12 Oct 2016
Carcinoid syndrome
Dr Rachel Riechelmann - Instituto do Câncer do Estado de São Paulo, São Paulo...
Carcinoid syndrome ( Dr Rachel Riechelmann - Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil )
12 Oct 2016
Who should receive combination therapy for ER positive breast cancer?
Dr Michael Gnant - Medizinischen Universität Wien, Vienna, Austria
Who should receive combination therapy for ER positive breast cancer? ( Dr Michael Gnant - Medizinischen Universität Wien, Vienna, Austria )
12 Oct 2016
Positive lessons of negative trials
Dr Bishal Gyawali - Nagoya University, Nagoya, Japan
Positive lessons of negative trials ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )
12 Oct 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation